Patents by Inventor Mitsutomo Miyashita

Mitsutomo Miyashita has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5449787
    Abstract: N,N'-disubstituted amide derivatives having potent and selective antagonistic action to 5-HT.sub.3 receptor have been developed by the present invention, which provides antagonistic drugs to 5-HT.sub.3 receptor containing novel N,N'-disubstituted amide derivatives represented by a general formula [I] ##STR1## (wherein R.sub.1 denotes a hydrogen atom or lower alkyl group, R.sub.2 and R.sub.3, which may be identical or different, denote respectively a hydrogen atom, lower alkyl group, lower alkenyl group, nonsubstituted or substituted aryl-lower alkyl group, acyl group or lower alkoxycarbonyl group, R.sub.4 denotes a hydrogen atom, lower alkyl group or lower alkoxy group, A denotes CH or N, and n denotes 1), their hydrates or acid addition salts.
    Type: Grant
    Filed: September 6, 1994
    Date of Patent: September 12, 1995
    Assignee: Kyorin Pharmaceutical Co., Ltd.
    Inventors: Mitsutomo Miyashita, Toshio Maeda, Fumio Kawahara, Fukutaro Taga
  • Patent number: 5242912
    Abstract: The following cyclic anthranilic acid derivative, their acid addition salts or alkali salts thereof represented by a general formula [I] are useful for antirheumatic drug, autoimmune disease curing drug and metabolic bone disease curing drug. ##STR1## wherein R.sup.1 to R.sup.6 and X are as defined in claim 1.
    Type: Grant
    Filed: April 25, 1991
    Date of Patent: September 7, 1993
    Assignee: Kyorin Pharmaceutical Co., Ltd.
    Inventors: Mitsutomo Miyashita, Yasushi Kohno, Eisuke Kojima, Koji Saito
  • Patent number: 5120743
    Abstract: Cyclic anthranilic acid acetic acid derivatives of the following formula, ##STR1## wherein R.sup.1 and R.sup.2 each independently indicate a hydrogen atom, lower alkyl group having 1 to 3 carbon atoms; their acid or alkali salts thereof are useful as drugs treat autoimmune diseases, antirheumatic agents and therapeutic or prophylactic agents to treat metabolic bone diseases.
    Type: Grant
    Filed: June 12, 1990
    Date of Patent: June 9, 1992
    Assignee: Kyorin Pharmaceutical Co., Ltd.
    Inventors: Mitsutomo Miyashita, Yasushi Kohno, Eisuke Kojima, Koji Saito
  • Patent number: 5077302
    Abstract: Urea derivatives of the following formula: ##STR1## wherein R.sub.2 indicates a piperidino or pyrrolidino group which may be substituted with a hydroxy group or a lower alkyl group having 1 to 13 carbon atoms; A indicates an ethylene group, propylene group, butylene group or butenylene group; R.sub.2 indicates a straight or branched alkyl group having 1 to 20 carbon atoms, a benzyl group, or a phenyl group which may have 1 to 3 substituents such as a lower alkyl group having 1 to 6 carbon atoms, a lower alkoxy group having 1 to 3 carbon atoms, a halogen atom, a trifluoromethyl group, an amino group, a nitro group or a methylenedioxy group; and X indicates an oxygen or sulfur atom, as well as the hydrates and pharmaceutically acceptable salts thereof are useful antiulcer agents.
    Type: Grant
    Filed: May 15, 1990
    Date of Patent: December 31, 1991
    Assignee: Kyorin Pharmaceutical Co., Ltd.
    Inventors: Hiroshi Matsukubo, Toyomi Matsumoto, Mitsutomo Miyashita, Kyuya Okamura, Fukutaro Taga, Haruo Sekiguchi, Katsuhiro Hamada
  • Patent number: 4952591
    Abstract: Urea derivatives of the following formula, ##STR1## wherein R.sub.1 indicates a piperidino group or pyrrolidino group which may be substituted with hydroxy group or lower alkyl group having 1 to 3 carbon atoms; A indicates an ethylene group, propylene group, butylene group or butenylene group; R.sub.2 indicates a straight or branched alkyl group having 1 to 20 carbon atoms, cycloalkyl group having 3 to 6 carbon atoms, benzyl group, or phenyl group which may have 1 to 3 substituents such as lower alkyl group having 1 to 6 carbon atoms, lower alkoxy group having 1 to 3 carbon atoms, halogen atom, trifluoromethyl group, amino group, nitro group or methylenedioxy group; X indicates an oxygen or sulfur atom, the hydrates and pharmaceutically acceptable acid addition salts thereof are useful as antiulcer agents.
    Type: Grant
    Filed: July 21, 1988
    Date of Patent: August 28, 1990
    Assignee: Kyorin Pharmaceutical Co., Ltd.
    Inventors: Hiroshi Matsukubo, Toyomi Matsumoto, Mitsutomo Miyashita, Kyuya Okamura, Fukutaro Taga, Haruo Sekiguchi, Katsuhiro Hamada